Pages • 1
Nehas Essay Preview: Nehas Report this essay ImClone Systems Incorporated (ImClone) is a “biopharmaceutical company that develops a portfolio of targeted biologic treatments designed to address the medical needs of patients with cancer.” ImClone Co. was founded in 1984. In 1986, the company opened its laboratories at 180 Varick Street in New York City. The.